Busey Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History

Busey Wealth Management

$2.99 Billion
Q4 2024

A detailed history of Busey Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Busey Wealth Management holds 1,490 shares of REGN stock, worth $1.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,490

Previous 1,563 4.67%

Holding current value

$1.04 Million

Previous $1.64 Million 35.42%

% of portfolio

0.04%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$701.85 - $1046.91 $51,235 - $76,424	-73 Reduced 4.67%	1,490 $1.06 Million
Q3 2024 Oct 23, 2024	SELL	$1024.09 - $1201.76 $232,468 - $272,799	-227 Reduced 12.68%	1,563 $1.64 Million
Q2 2024 Jul 23, 2024	SELL	$883.2 - $1071.19 $81,254 - $98,549	-92 Reduced 4.89%	1,790 $1.88 Million
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $103,809 - $114,235	-115 Reduced 5.76%	1,882 $1.81 Million
Q4 2023 Jan 25, 2024	BUY	$775.18 - $881.7 $12,402 - $14,107	16 Added 0.81%	1,997 $1.75 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $220,891 - $269,354	-319 Reduced 13.87%	1,981 $1.63 Million
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $36,401 - $43,178	-52 Reduced 2.21%	2,300 $1.65 Million
Q1 2023 Apr 25, 2023	SELL	$680.49 - $826.97 $45,592 - $55,406	-67 Reduced 2.77%	2,352 $1.93 Million
Q4 2022 Jan 23, 2023	SELL	$705.89 - $766.39 $23,294 - $25,290	-33 Reduced 1.35%	2,419 $0
Q3 2022 Oct 24, 2022	SELL	$573.97 - $724.32 $78,633 - $99,231	-137 Reduced 5.29%	2,452 $1.69 Million
Q2 2022 Aug 01, 2022	SELL	$548.35 - $738.84 $212,211 - $285,931	-387 Reduced 13.0%	2,589 $1.53 Million
Q1 2022 Apr 21, 2022	SELL	$595.12 - $698.43 $20,829 - $24,445	-35 Reduced 1.16%	2,976 $2.08 Million
Q4 2021 Jan 25, 2022	SELL	$543.48 - $670.97 $70,108 - $86,555	-129 Reduced 4.11%	3,011 $1.9 Million
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $190,577 - $226,078	-332 Reduced 9.56%	3,140 $1.9 Million
Q2 2021 Jul 22, 2021	SELL	$472.8 - $558.54 $65,719 - $77,637	-139 Reduced 3.85%	3,472 $1.94 Million
Q1 2021 Apr 20, 2021	SELL	$446.73 - $548.2 $109,448 - $134,309	-245 Reduced 6.35%	3,611 $1.71 Million
Q4 2020 Jan 20, 2021	SELL	$478.3 - $607.98 $76,528 - $97,276	-160 Reduced 3.98%	3,856 $1.86 Million
Q3 2020 Oct 16, 2020	SELL	$544.75 - $658.21 $34,864 - $42,125	-64 Reduced 1.57%	4,016 $2.25 Million
Q2 2020 Jul 21, 2020	SELL	$493.32 - $643.92 $34,039 - $44,430	-69 Reduced 1.66%	4,080 $2.55 Million
Q1 2020 Apr 17, 2020	SELL	$336.18 - $494.43 $6,387 - $9,394	-19 Reduced 0.46%	4,149 $2.03 Million
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $201,485 - $276,734	-735 Reduced 14.99%	4,168 $1.57 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $1.34 Million - $1.56 Million	4,903 New	4,903 $1.36 Million

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.

Account

Busey Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History